U.S. Oncology realigns executive team
The board of directors of U.S. Oncology has reported that Dale Ross will transition out of his role as CEO and will continue as the executive chairman of the company, effective February 1.
Bruce D. Broussard will become the Houston-based company's president and CEO at that time, which the company said is a planned succession that follows Broussard’s promotion to president in November 2005. Broussard, who joined U.S. Oncology in August 2000, was also elected to the board, on Feb. 1.
Bruce D. Broussard will become the Houston-based company's president and CEO at that time, which the company said is a planned succession that follows Broussard’s promotion to president in November 2005. Broussard, who joined U.S. Oncology in August 2000, was also elected to the board, on Feb. 1.